BioLineRx (BLRX) EBT (2023 - 2025)
Historic EBT for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to -$1.9 million.
- BioLineRx's EBT rose 4941.52% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61000.0, marking a year-over-year increase of 10023.86%. This contributed to the annual value of -$11.3 million for FY2024, which is 7624.62% up from last year.
- As of Q3 2025, BioLineRx's EBT stood at -$1.9 million, which was up 4941.52% from -$2.0 million recorded in Q2 2025.
- In the past 5 years, BioLineRx's EBT ranged from a high of $6.0 million in Q4 2024 and a low of -$14.2 million during Q4 2023
- For the 3-year period, BioLineRx's EBT averaged around -$4.9 million, with its median value being -$3.8 million (2024).
- Its EBT has fluctuated over the past 5 years, first surged by 14190.62% in 2024, then soared by 4503.8% in 2025.
- BioLineRx's EBT (Quarter) stood at -$14.2 million in 2023, then skyrocketed by 141.91% to $6.0 million in 2024, then tumbled by 131.92% to -$1.9 million in 2025.
- Its last three reported values are -$1.9 million in Q3 2025, -$2.0 million for Q2 2025, and -$2.0 million during Q1 2025.